Gold Falls 1%; Charter Communications Shares Fall After Q3 Results
U.S. stocks gained Friday, led by Nasdaq +1.5%, as jobs beat forecasts. Gogo and JFrog surged, while DraftKings and Biodesix plunged.
Stocks · News reference
Charter Stock Drops 5% as Internet Customer Losses Overshadow Cox Merger Boost, Massive $3 Billion Cost-Cutting Turnaround and More
Charter Communications stock falls 5% following mixed Q3 earnings and persistent broadband customer losses. Here is how its $3B turnaround plan impacts investors.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Charter Communications Q3 2026 Earnings Call Transcript
Charter Communications (NASDAQ:CHTR) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by
Charter Communications Reports Third Quarter 2026 Results and New Operating Model
Charter Communications announced its third-quarter 2026 financial results, reporting revenue of $14.92 billion and a loss of $20.50 per share, while simultaneously introducing a new operating model.
Nasdaq Tumbles 5.5% as AI Stocks Crater: Investor Sentiment Weakens, Fear & Greed Index Moves to ‘Extreme Fear’ Zone
Markets plunged as AI stocks rout deepened, pushing CNN’s Fear & Greed Index to Extreme Fear; Nasdaq fell 5.5%, while AMD and Micron dropped 17%.
Airbnb, Charter Communications and 3 Stocks to Watch Heading Into Friday
Charter, Humana and Fluor report earnings; Microchip beat estimates but cut guidance, while Airbnb topped forecasts and surged 11%.
Enbridge, Moderna On Deck Friday As Demand, Vaccine Pipeline Face Test
Enbridge headlines Friday’s reports, with investors weighing whether resilient pipeline utilization can offset a softer revenue comparison. Moderna, Brookfield Asset Management, Humana, Vistra, PPL, Plains All American